Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIYELA: Bexsero for Gonorrhea Prevention in Women
NCT06446752Phase 3Active, not recruiting
- Sponsor
- University of Washington
- Start
- Aug 2024
- Primary completion
- Oct 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal group B vaccine in gonorrhea, sponsored by University of Washington. Started Aug 2024; status: active, not recruiting.
02
Drugs
meningococcal group B vaccine
03
Conditions
gonorrhea
Beyond the preview
Go deeper on NCT06446752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06446752.